Table 5.
Patients, n (%) | ||
Any grade | Grade ≥3 | |
Any immune-related adverse event | 31 (19.9) | 1 (0.6) |
Immune-mediated thyroid disorder | 15 (9.6) | 0 |
Hypothyroidism | 14 (9.0) | 0 |
Hyperthyroidism | 1 (0.6) | 0 |
Immune-mediated rash or pruritus | 12 (7.7) | 0 |
Pruritus | 6 (3.8) | 0 |
Rash | 6 (3.8) | 0 |
Rash maculopapular | 2 (1.3) | 0 |
Pruritus generalized | 1 (0.6) | 0 |
Rash erythematous | 1 (0.6) | 0 |
Rash macular | 1 (0.6) | 0 |
Immune-mediated pneumonitis | 5 (3.2) | 1 (0.6) |
Immune-mediated colitis | 3 (1.9) | 0 |
Diarrhea | 2 (1.3) | 0 |
Colitis | 1 (0.6) | 0 |
Immune-mediated adrenal insufficiency | 1 (0.6) | 0 |
Autoimmune disorder | 1 (0.6) | 0 |